FDA Device recall Z-2387-2021
Merge Hemo, Software packages 10.2, 10.3, and 10.4
- FDA Device
- Class II
- terminated
- Published 2021-09-08
On 2021-09-08 the FDA classified a Class II recall of Merge Hemo, Software packages 10.2, 10.3, and 10.4 by Merge Healthcare, citing the firm identified a safety issue affecting the software associated with Merge Hemo versions 9.x and 10.x, used in combination with an HL7 lab interface.
Read the official FDA Device notice
| Agency | FDA Device |
|---|---|
| Recall number | Z-2387-2021 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2021-07-23 |
| Published | 2021-09-08 |
| Last updated | 2026-09-13 11:56 UTC |
| Company | Merge Healthcare |
| Distribution | n/a |
Product
Merge Hemo, Software packages 10.2, 10.3, and 10.4
Reason
The firm identified a safety issue affecting the software associated with Merge Hemo versions 9.x and 10.x, used in combination with an HL7 lab interface.
Identifiers
| code_info | Version 10.2, UDI (01)00842000100430(10)10.2(11)190612 Version 10.3, UDI (01)00842000100874(10)10.3(11)200330 Version…Version 10.2, UDI (01)00842000100430(10)10.2(11)190612 Version 10.3, UDI (01)00842000100874(10)10.3(11)200330 Version 10.4, UDI (01)00842000100966(10)10.4(11)210428 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:56 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-2387-2021%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.